Local business Emergent Biosolutions has played a major role in manufacturing the newest vaccine available to combat the COVID-19 virus.
The global life sciences company, whose mission is to protect and enhance life, has been hard at work developing drug substances for COVID-19 vaccines, including the latest to be authorized by the U.S. Food and Drug Administration (FDA).
The Johnson & Johnson vaccine recently received Emergency Use Authorization, with plans to deliver 100 million doses across the country during the first half of the year. Maryland will begin distributing the third available vaccine in early March.
READ FULL ARTICLE HERE
